{
    "nct_id": "NCT05359848",
    "official_title": "A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Protein Diet in Cancer Patients Receiving Chemotherapy",
    "inclusion_criteria": "* • Histologically documented, cancer patients who are eligible to receive cytotoxic chemotherapy.\n\n  * Life expectancy of at least 6 months\n  * Adults ≥ 18 years of age\n  * Adequate hematologic, renal, and liver function as evidenced by the following:\n\n    * White blood cell (WBC) ≥ 2,500 cells/μL\n    * Absolute neutrophil count (ANC) ≥ 1,000 cells/μL\n    * Platelet Count ≥ 100,000 cells/μL\n    * Hemoglobin (HgB) ≥ 9.0 g/dL\n    * Creatinine ≤ 2.0 mg/dL\n    * Total bilirubin ≤ 2 x upper limit of normal (ULN)\n    * Aspartate aminotransaminase (AST, SGOT) ≤ 2.5 x ULN\n    * Alanine aminotransaminase (ALT, SGPT) ≤ 2.5 x ULN\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* • Eastern Cooperative Oncology Group (ECOG) performance status 2 or higher\n\n  * Treatment with any of the following medications or interventions within 28 days of registration:\n\n    * Systemic corticosteroids; however, use of inhaled, intranasal, and topical steroids is acceptable.\n    * High dose calcitriol [1,25(OH)2VitD] (i.e., > 7.0 μg/week)\n  * Any infection requiring parenteral antibiotic therapy or causing fever (temperature > 100.5°F or 38.1°C) within 1 week prior to registration\n  * A known allergy, intolerance, or medical contraindication to receiving the contrast dye required for the protocol-specified CT/MRI imaging\n  * Any medical intervention or other condition which, in the opinion of the Principal Investigator, could compromise adherence with study requirements or otherwise compromise the study's objectives",
    "miscellaneous_criteria": ""
}